Comparison between whole-body magnetic resonance imaging and whole-body metaiodobenzylguanidine scintigraphy in the evaluation of primary tumor and metastases in neuroblastoma

被引:0
|
作者
Rodrigues, Monica Matos Correia [1 ]
Lederman, Henrique Manoel [2 ]
Grossman, Iona [2 ]
Castiglioni, Mario Luiz V. [3 ]
Marchetti, Renata [3 ]
Grass, Daphne Centola [2 ]
Luisi, Flavio Augusto Vercillo [1 ,4 ]
Caran, Eliana Maria Monteiro [1 ]
机构
[1] Univ Fed Sao Paulo, Paulista Sch Med, Support Grp Adolescents & Children Canc, Div Pediat Oncol,Inst Pediat Oncol, Sao Paulo, SP, Brazil
[2] Univ Fed Sao Paulo, Paulista Sch Med, Support Grp Adolescents & Children Canc IOP GRAACC, Div Radiol,Inst Pediat Oncol, Sao Paulo, SP, Brazil
[3] Fed Univ Sao Paulo UNIFESP, Imaging Diagnost Dept DDI, Nucl Med, HU, Sao Paulo, SP, Brazil
[4] Fed Univ Sao Paulo EPM UNIFESP, Paulista Sch Med, Support Grp Adolescents & Children Canc IOP GRAACC, Div Pediat Oncol,Inst Pediat Oncol, BR-04023062 Sao Paulo, SP, Brazil
关键词
MIBG; MRI; neoplasm staging; neuroblastoma; nuclear medicine; whole-body scintigraphy; DIFFUSION-WEIGHTED MRI; I-123-MIBG SCINTIGRAPHY; DIAGNOSTIC-VALUE; F-18-FDG PET; CHILDREN; DIFFERENTIATION; CT;
D O I
10.1002/pbc.30820
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
BackgroundWhole-body metaiodobenzylguanidine (131I-MIBG) scintigraphy is the gold standard method to detect neuroblastoma; however, it depends on radioactive material and is expensive. In contrast, whole-body magnetic resonance imaging (WB-MRI) is affordable in developing countries and has been shown to be effective in the evaluation of solid tumors. This study aimed to compare the sensitivity and specificity of WB-MRI with MIBG in the detection of primary tumors and neuroblastoma metastases.ProcedureThis retrospective study enrolled patients with neuroblastoma between 2013 and 2020. All patients underwent WB-MRI and MIBG at intervals of up to 15 days. The results were marked in a table that discriminated anatomical regions for each patient. Two experts evaluated, independently and in anonymity, the WB-MRI images, and two others evaluated MIBG. The results were compared in terms of sensitivity and specificity, for each patient, considering MIBG as the gold standard. This study was approved by the UNIFESP Ethics Committee.ResultsThirty patients with neuroblastoma were enrolled in this study. The age ranged from 1 to 15 years, with a mean of 5.7 years. The interval between exams (WB-MRI and MIBG) ranged from 1 to 13 days, with an average of 6.67 days. Compared to MIBG, WB-MRI presented a sensitivity and specificity greater than or equal to 90% for the detection of primary neuroblastoma in bones and lymph nodes. When we consider the patient without individualizing the anatomical regions, WB-MRI presented sensitivity of 90% and specificity of 73.33%.ConclusionIn conclusion, WB-MRI is a sensitive and specific method to detect neuroblastoma in bone and lymph nodes and highly sensible to primary tumor diagnosis, suggesting that this test is a viable alternative in places where MIBG is difficult to access. Studies with a larger number of cases are necessary for definitive conclusions.
引用
收藏
页数:6
相关论文
共 50 条
  • [21] Whole-body magnetic resonance angiography
    Weir-McCall, J. R.
    Bonnici-Mallia, M.
    Ramkumar, P. G.
    Nath, A. F.
    Houston, J. G.
    CLINICAL RADIOLOGY, 2019, 74 (01) : 3 - 12
  • [22] Whole-body MRI of neuroblastoma
    Goo, Hyun Woo
    EUROPEAN JOURNAL OF RADIOLOGY, 2010, 75 (03) : 306 - 314
  • [23] Evaluation of CSF flow by whole-body scintigraphy
    Wong, Franklin
    McCutcheon, Ian
    Groves, Morris
    Kim, E.
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
  • [24] An aggressive neuroendocrine tumor with whole-body metastases
    Timmers, Marijke
    Driessen, Ann
    Van den Brande, Jan
    Moorkens, Greta
    Michielsen, Peter
    ACTA CLINICA BELGICA, 2015, 70 : 19 - 19
  • [25] Simultaneous Positron Emission Tomography/Magnetic Resonance Imaging for Whole-Body Staging in Patients With Recurrent Gynecological Malignancies of the Pelvis A Comparison to Whole-Body Magnetic Resonance Imaging Alone
    Grueneisen, Johannes
    Beiderwellen, Karsten
    Heusch, Philipp
    Gratz, Marcel
    Schulze-Hagen, Antonia
    Heubner, Martin
    Kinner, Sonja
    Forsting, Michael
    Lauenstein, Thomas
    Ruhlmann, Verena
    Umutlu, Lale
    INVESTIGATIVE RADIOLOGY, 2014, 49 (12) : 808 - 815
  • [26] Whole-body magnetic resonance imaging in the detection of skeletal metastases in patients with prostate cancer
    Venkitaraman, R.
    Cook, G. J. R.
    Dearnaley, D. P.
    Parker, C. C.
    Khoo, V.
    Eeles, R.
    Huddart, R. A.
    Horwich, A.
    Sohaib, S. A.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2009, 53 (03) : 241 - 247
  • [27] Whole-Body Magnetic Resonance Imaging in Oncology: Uses and Indications
    Petralia, Giuseppe
    Padhani, Anwar R.
    MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2018, 26 (04) : 495 - +
  • [28] A WHOLE-BODY NUCLEAR MAGNETIC-RESONANCE IMAGING MACHINE
    EDELSTEIN, WA
    HUTCHISON, JMS
    JOHNSON, G
    REDPATH, TW
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 1981, 5 (02) : 292 - 292
  • [29] Whole-Body Magnetic Resonance Imaging in Skeletal Muscle Disease
    Shelly, Martin J.
    Bolster, Ferdia
    Foran, Paul
    Crosbie, Ian
    Kavanagh, Eoin C.
    Eustace, Stephen J.
    SEMINARS IN MUSCULOSKELETAL RADIOLOGY, 2010, 14 (01) : 47 - 56
  • [30] Variability in billing practices for whole-body magnetic resonance imaging
    Degnan, Andrew J.
    Alson, Mark D.
    Duszak, Richard, Jr.
    PEDIATRIC RADIOLOGY, 2019, 49 (01) : 153 - 153